Terms: = Pancreatic cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
57 results:
1. Analysis of clinicopathological characteristics and prognostic factors of early-stage human epidermal growth factor receptor 2 (HER2)-low breast cancer: Compared with HER2-0 breast cancer.
Wu Q; Yang F; Liu Y; Zhang H; Zhang S; Xin L; Xu L
Cancer Med; 2023 Oct; 12(19):19560-19575. PubMed ID: 37772432
[TBL] [Abstract] [Full Text] [Related]
2. Spinster homolog 2 reduces malignancies of glioblastoma via pten/PI3K/AKT pathway.
Liang W; Liu M; Su Y; Wen Y; Wang L; Shan J; Zhao J; Xie K; Wang J
IUBMB Life; 2024 Mar; 76(3):140-160. PubMed ID: 37728571
[TBL] [Abstract] [Full Text] [Related]
3. MYC Deregulation and pten Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast cancer.
Doha ZO; Wang X; Calistri NL; Eng J; Daniel CJ; Ternes L; Kim EN; Pelz C; Munks M; Betts C; Kwon S; Bucher E; Li X; Waugh T; Tatarova Z; Blumberg D; Ko A; Kirchberger N; Pietenpol JA; Sanders ME; Langer EM; Dai MS; Mills G; Chin K; Chang YH; Coussens LM; Gray JW; Heiser LM; Sears RC
Nat Commun; 2023 Sep; 14(1):5665. PubMed ID: 37704631
[TBL] [Abstract] [Full Text] [Related]
4. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract] [Full Text] [Related]
5. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and Metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
6. circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through pten mediated PI3K/AKT signaling pathway.
Xu C; Ye Q; Ye C; Liu S
Biol Direct; 2023 Mar; 18(1):14. PubMed ID: 36991449
[TBL] [Abstract] [Full Text] [Related]
7. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review.
Farasati Far B; Vakili K; Fathi M; Yaghoobpoor S; Bhia M; Naimi-Jamal MR
Life Sci; 2023 Mar; 316():121340. PubMed ID: 36586571
[TBL] [Abstract] [Full Text] [Related]
8. Loss of KLK4::KLKP1 pseudogene expression by RNA chromogenic in-situ hybridization is associated with pten loss and increased risk of biochemical recurrence in a cohort of middle eastern men with prostate cancer.
Bakker A; Slack JC; Palanisamy N; Carskadon S; Ghosh S; Khalifeh I; Bismar TA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3721-3728. PubMed ID: 35982181
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Yamamoto Y; Ashida R; Ohgi K; Nagashima T; Yamaguchi K
J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):269-282. PubMed ID: 35918906
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and molecular profile of grade 3 gastroenteropancreatic neuroendocrine neoplasms.
Taboada R; Claro L; Felismino T; de Jesus VH; Barros M; Riechelmann RP
J Neuroendocrinol; 2022 Apr; 34(4):e13099. PubMed ID: 35174558
[TBL] [Abstract] [Full Text] [Related]
11. Positive feedback between lncRNA FLVCR1-AS1 and KLF10 may inhibit pancreatic cancer progression via the pten/AKT pathway.
Lin J; Zhai S; Zou S; Xu Z; Zhang J; Jiang L; Deng X; Chen H; Peng C; Zhang J; Shen B
J Exp Clin Cancer Res; 2021 Oct; 40(1):316. PubMed ID: 34635142
[TBL] [Abstract] [Full Text] [Related]
12. mTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs.
Borga C; Dal Pozzo CA; Trevellin E; Bergamo F; Murgioni S; Milanetto AC; Pasquali C; Cillo U; Munari G; Martini C; De Carlo E; Zagonel V; Guzzardo V; Pennelli G; Dei Tos AP; Vettor R; Fassan M
Endocr Relat Cancer; 2021 Jun; 28(7):449-456. PubMed ID: 33974555
[TBL] [Abstract] [Full Text] [Related]
13. Olaparib Monotherapy for Previously Treated pancreatic cancer With DNA Damage Repair Genetic Alterations Other Than Germline BRCA Variants: Findings From 2 Phase 2 Nonrandomized Clinical Trials.
Javle M; Shacham-Shmueli E; Xiao L; Varadhachary G; Halpern N; Fogelman D; Boursi B; Uruba S; Margalit O; Wolff RA; Golan T
JAMA Oncol; 2021 May; 7(5):693-699. PubMed ID: 33662100
[TBL] [Abstract] [Full Text] [Related]
14. EIF3B promotes cancer progression in pancreatic cancer.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of genetic alterations in endoscopically obtained pancreatic cancer specimens.
Takano S; Fukasawa M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Kuratomi N; Kadokura M; Maekawa S; Sato T; Enomoto N
Cancer Med; 2021 Feb; 10(4):1264-1274. PubMed ID: 33455072
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Liu JQ; Liao XW; Wang XK; Yang CK; Zhou X; Liu ZQ; Han QF; Fu TH; Zhu GZ; Han CY; Su H; Huang JL; Ruan GT; Yan L; Ye XP; Peng T
BMC Gastroenterol; 2020 Dec; 20(1):415. PubMed ID: 33302876
[TBL] [Abstract] [Full Text] [Related]
17. Oroxylin A Exerts Its Antitumor Effects in Human Gallbladder cancer via Inhibition of the pten/PI3K/AKT Signaling Pathway.
Xuan L; Zhang J; Ji J; Hu J; Li F
Biol Pharm Bull; 2020; 43(10):1511-1518. PubMed ID: 32999161
[TBL] [Abstract] [Full Text] [Related]
18. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating pten/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract] [Full Text] [Related]
19. N
Tian J; Zhu Y; Rao M; Cai Y; Lu Z; Zou D; Peng X; Ying P; Zhang M; Niu S; Li Y; Zhong R; Chang J; Miao X
Gut; 2020 Dec; 69(12):2180-2192. PubMed ID: 32312789
[TBL] [Abstract] [Full Text] [Related]
20. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer.
Wu F; Chen Y; Zhu J
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32186702
[TBL] [Abstract] [Full Text] [Related]
[Next]
